About Us
About Us
A Next Generation Biosimilars Company
A Next Generation Biosimilars Company
Recent advancements in Continuous Manufacturing (CM), artificial intelligence and machine learning (AI/ML) and anticipated regulatory shifts—such as the potential waiver of Phase III clinical trials—have paved the way for a new biosimilar development and manufacturing company. Ardent Biopharma is seizing this opportunity to redefine cost efficiency in the production of monoclonal antibodies (mAbs) and other therapeutic proteins.
Recent advancements in Continuous Manufacturing (CM), artificial intelligence and machine learning (AI/ML) and anticipated regulatory shifts—such as the potential waiver of Phase III clinical trials—have paved the way for a new biosimilar development and manufacturing company. Ardent Biopharma is seizing this opportunity to redefine cost efficiency in the production of monoclonal antibodies (mAbs) and other therapeutic proteins.
Cost leader in the biosimilars industry
Cost leader in the biosimilars industry
Leveraging these innovations, we aim to deliver biosimilars below 20% of the originator price, significantly improving global affordability and accessibility to life-saving or life-enhancing biologic therapies. Ardent aspires to become a cost leader in the biosimilars industry. Both first and second wave biosimilars will be developed.
Development will be done in close collaboration with our partners until we can operate from a proprietary facility. Future product M&S will be realized through specialized parties per region.
Leveraging these innovations, we aim to deliver biosimilars below 20% of the originator price, significantly improving global affordability and accessibility to life-saving or life-enhancing biologic therapies. Ardent aspires to become a cost leader in the biosimilars industry. Both first and second wave biosimilars will be developed.
Development will be done in close collaboration with our partners until we can operate from a proprietary facility. Future product M&S will be realized through specialized parties per region.
Our Team
Our Team
Management team
Management team
Ardent Biopharma’s core team brings together over 100 years of combined experience in biologics development and manufacturing, with deep expertise in Continuous Manufacturing of monoclonal antibodies.
Ardent Biopharma’s core team brings together over 100 years of combined experience in biologics development and manufacturing, with deep expertise in Continuous Manufacturing of monoclonal antibodies.
